Product: | 1,2-Benzisoxazole-3-methanesulfonate sodium salt | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 4773 | ||||||||
CAS Number: | 73101-64-1 | ||||||||
Synonyms: | Zonisamide related compound A | ||||||||
Pricing: |
|
||||||||
Formula: | C8H6NNaO4S | ||||||||
Chemical Purity: | 95% | ||||||||
Molecular Weight: | 235.19 | ||||||||
Appearance: | Solid | ||||||||
Category: | Unlabeled Reference Standards | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well ventilated place |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Tomson., T., Johannessen, S., Therapeutic monitoring of the new antiepileptic drugs. Eur. J. Pharmacol. 55, 697, (2000); Noda, Y., et al., Zonisamide inhibits nitric oxide synthase activity induced by N-methyl-D-aspartate and buthionine sulfoximine in the rat hippocampus. Res. Commun. Mol. Pathol. Pharmacol. 105, 23, (1999); Merck 14,10192 |
||||||||
MSDS: | |||||||||
Description: |
Zonisamide sodium salt is an anti-epileptic. It is effective in various animal epilepsy models and humans with both partial and generalized epileptic seizures. Zonisamide sodium salt also scavenges nitric oxide (NO). |